KNSA — Kiniksa Pharmaceuticals International plc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Kiniksa Pharmaceuticals International plc (KNSA), worth $20.12M combined. Over the quarter 1 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Essex | $15.44M | 2.00% | -3.2% |
| Renaissance | $4.35M | 0.00% | NEW |
| BIT | $328.57K | 0.01% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.